Trials / Completed
CompletedNCT05213832
Effect of Inhalatory Sedation in Subarachnoid Hemorrhage
Effect of Inhalatory Sedation on Cerebral Perfusion in Subarachnoid Hemorrhage
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- A.O.U. Città della Salute e della Scienza · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effect of inhalational sedation on cerebral perfusion in patients with SAH. It will evaluate whether the administration of isofluorane, by inducing direct vasodilation in the cerebral parenchyma, can improve the cerebral perfusion rates. Perfusional CT will be used to study the variation of cerebral blood flow to rule out the vasodilatory effect on territories with different cerebrovascular reactivity aggravating the phenomena of distrectual hypoperfusion (theft theory).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isoflurane Inhal Soln | Administration of isofluorane in patients with severe SAH |
Timeline
- Start date
- 2020-06-26
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-01-28
- Last updated
- 2024-02-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05213832. Inclusion in this directory is not an endorsement.